AstraZeneca PLC's Fiscal Year is From January To December - All Figures are in USD, Billions.
The item "Cash-and-Short-Term-Investments" stands at 8.18 Billion United States Dollars as of 09/30/2025, the highest value since 09/30/2021.
As of the end of AstraZeneca PLC's third quarter, the item "Cash and Short Term Investments" stands at 8.18 Billion USD. This represents an increase of 15.02 percent compared to it's value at the end of it's second quarter .
Regarding the One-Year-Change of the series, the current value constitutes an increase of 66.34 percent compared to the value the year prior.
The 1 year change in percent is 66.34.
The 3 year change in percent is 68.55.
The 5 year change in percent is -2.96.
The 10 year change in percent is 78.76.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Cash and Short Term Investments | 905,699,262,464.00 |
![]() | Johnson & Johnson - Cash and Short Term Investments | 486,508,953,600.00 |
![]() | AbbVie Inc - Cash and Short Term Investments | 399,570,305,024.00 |
![]() | Roche Holding AG - Cash and Short Term Investments | 317,433,206,677.55 |
![]() | Novartis AG - Cash and Short Term Investments | 255,096,620,580.91 |